Overview of Dyslipidaemia in Adults

Mohammad Shoaib Hamrah^1*, Mohammad Hassan Hamrah^2,5, Mohammad Hussain Hamrah^3,5, Toba Dahi⁴, Ahmad Edris Hamrah⁵ & Mohammad Hashem Hamrah⁵

¹Center for Rural Health, School of Health Sciences, University of Tasmania, Australia
²Faculty of Stomatology, Kunduz University, Kunduz, Afghanistan
³Arya University Faculty of Medicine, Mazar-i-Sharif, Afghanistan
⁴Faculty of Dentistry, AbantIzzet Baysal University, Bolu, Turkey
⁵Dr.Mohammad Hashem Hamrah’s Curative Clinic

Dr. Mohammad Shoaib Hamrah, Centre for Rural Health, School of Health Sciences, University of Tasmania, Australia.

Keywords: Dyslipidaemia; CVD; Atherosclerosis

Abstract

Dyslipidaemia is a risk factor for atherosclerotic cardiovascular disease (ASCVD) including coronary artery disease (CAD), stroke, and peripheral artery disease. Control of lipid levels is the most effective intervention in both primary and secondary prevention of ASCVD. The combination of therapeutic lifestyle changes and pharmacologic treatment can be used for the management of patients with dyslipidaemia. This article explains the recent changes in guidelines for screening and management of dyslipidaemia among adults.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).